BeiGene (BGNE) Short Interest Ratio & Short Volume

Short interest is the volume of BeiGene shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 1,090,000 shares of BGNE short. Learn More on BeiGene's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BGNE shares currently have a short interest ratio of 3.0. Learn More on BeiGene's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BeiGene: Barclays PLC, and Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

BeiGene saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 1,090,000 shares, a decrease of 27.8% from the previous total of 1,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to BeiGene: BioMarin Pharmaceutical Inc. (2.82%), Alnylam Pharmaceuticals, Inc. (2.87%), GSK plc (0.80%), Takeda Pharmaceutical Company Limited (0.19%), BioNTech SE (0.84%), Teva Pharmaceutical Industries Limited (1.60%), Viatris Inc. (2.09%), Summit Therapeutics Inc. (2.31%), Moderna, Inc. (10.02%), Genmab A/S (0.37%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling BGNE is an investing strategy that aims to generate trading profit from BeiGene as its price is falling. BGNE shares are trading up $6.49 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BeiGene occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BGNE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BGNE, twice per month. The most recent reporting period available is October, 31 2024.